These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11903734)

  • 1. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis.
    Adachi K; Fujishiro H; Katsube T; Yuki M; Ono M; Kawamura A; Rumi MA; Watanabe M; Kinoshita Y
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1191-6. PubMed ID: 11903734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low-grade esophagitis with low reflux burden.
    Zhang M; Tan N; Li Y; Chen M; Xiao Y
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13702. PubMed ID: 31407469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dental erosions in patients with gastroesophageal reflux disease in National Hospital Arzobispo Loayza].
    Torres Vargas L; Torres Vargas N; Vargas Cárdenas G
    Rev Gastroenterol Peru; 2012; 32(4):343-50. PubMed ID: 23307083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease.
    Visaggi P; Del Corso G; Gyawali CP; Ghisa M; Baiano Svizzero F; Stefani Donati D; Venturini A; Savarino V; Penagini R; Zeki S; Bellini M; Savarino EV; de Bortoli N
    Am J Gastroenterol; 2023 May; 118(5):794-801. PubMed ID: 36633477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest That Factors Other Than Gastroesophageal Reflux Contribute to its Pathogenesis.
    Nguyen AD; Spechler SJ; Shuler MN; Souza RF; Dunbar KB
    J Clin Gastroenterol; 2019 Jan; 53(1):9-14. PubMed ID: 28644313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
    Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
    Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease.
    Pilic D; Hankel S; Koerner-Rettberg C; Hamelmann E; Schmidt-Choudhury A
    Scand J Gastroenterol; 2013 Jul; 48(7):785-93. PubMed ID: 23795658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is pH Testing Necessary Before Antireflux Surgery in Patients with Endoscopic Erosive Esophagitis?
    Schwameis K; Lin B; Roman J; Olengue K; Siegal S; DeMeester SR
    J Gastrointest Surg; 2018 Jan; 22(1):8-12. PubMed ID: 28842858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
    Dunbar KB; Agoston AT; Odze RD; Huo X; Pham TH; Cipher DJ; Castell DO; Genta RM; Souza RF; Spechler SJ
    JAMA; 2016 May; 315(19):2104-12. PubMed ID: 27187303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis.
    Hsu PI; Lu CL; Wu DC; Kuo CH; Kao SS; Chang CC; Tai WC; Lai KH; Chen WC; Wang HM; Cheng JS; Tsai TJ; Chuah SK
    Clin Gastroenterol Hepatol; 2015 May; 13(5):859-66.e1. PubMed ID: 25245625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy for nocturnal gastric acid breakthrough].
    Kinoshita Y; Adachi K
    Nihon Rinsho; 2000 Sep; 58(9):1853-8. PubMed ID: 11004815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory intraesophageal bilirubin monitoring in Japanese patients with gastroesophageal reflux.
    Osugi H; Higashino M; Kaseno S; Takada N; Takemura M; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
    J Gastroenterol; 2002; 37(9):697-702. PubMed ID: 12375142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal motility in patients with sliding hiatal hernia with reflux esophagitis.
    Ye P; Li ZS; Xu GM; Zou DW; Xu XR; Lu RH
    Chin Med J (Engl); 2008 May; 121(10):898-903. PubMed ID: 18706203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.